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The objective of this study was to assess the inhibitory effect of potential negative regulatory elements on human
immunodeficiency virus (HIV)-1 long terminal repeat (LTR) activity. This was carried out by pairwise comparisons of reporter
gene activities of HIV –LTR–CAT constructs differing in the presence and absence of nef sequences in transient transfection
assays. Parallel transfections were performed in two persistently HIV-infected cell lines and the uninfected parental cell
lines. The negative regulatory element (NRE) of the LTR did not suppress HIV LTR activity in any of the cell lines examined.
However, a non-LTR-derived fragment of the nef gene had a distinct suppressive effect on activity of the full-length LTR in
chronically infected astrocytoma cells. A weaker negative effect of this nef partial sequence (nps) was detected in the other
cell lines with constructs lacking the NRE. The nps was capable of suppressing LTR activity in trans in chronically infected
astrocytoma cells in a concentration-dependent manner. These results stress a negative role of a non-LTR nef partial
sequence in a cell-specific manner. In addition, our data indicate that nps functions in trans with promoters unrelated to
HIV LTR such as SV40 early and CMV immediate–early promoters. q 1996 Academic Press, Inc.
The human immunodeficiency virus (HIV) is the caus- ity. Repression of HIV LTR activity has been shown in
response to external stimuli such as CD8 antiviral factorative agent of acquired immunodeficiency syndrome
(AIDS) and AIDS-associated neurological diseases. Like (24), melittin (Wachinger et al., manuscript in prepara-
tion), and antibodies against CD4 (2). A negative regula-all retroviruses, a DNA copy of the virus integrates into
the host cell genome, in which it is expressed and perpet- tory effect has been attributed to the LTR region upstream
of nucleotide 0156 (relative to the RNA start site), baseduated like endogenous cellular genes. Expression levels
of the viral transcripts can vary widely, depending on the on increased LTR-directed gene expression of the de-
leted HIV LTR compared to the full-length LTR in thetype of the infected target cell and its state of activation
and differentiation. presence and absence of Tat (13, 22, 23, 32). This region,
Long terminal repeats (LTRs), flanking both ends of which is called the negative regulatory element (NRE),
the proviral genome, are the major determinants of viral contains several of the binding sites for nuclear factors,
gene expression. They contain enhancer, promoter, and some of which have been reported to exert a repressive
poly(A) signals and control transcriptional initiation (5* effect on the HIV LTR (13, 23, 27, 30, 36, 43). However,
LTR) and termination (3* LTR) (41). The LTRs have a the NRE did not show a consistently negative effect in
complex architecture (for reviews see 8, 11, 18, 39) and all studies (13, 16, 23), so that a general suppressive
contain binding sites for various cellular transcription activity of this region remains controversial. Therefore it
factors capable of modulating HIV gene expression (7, is still unclear which viral elements are involved in nega-
9, 12, 13, 15, 19, 30, 34, 36, 38, 44, 45). tive regulation of the HIV LTR activity and to what extent
The activity of the 5* LTR is greatly increased by the this effect differs between cell types.
viral transactivator Tat. In the absence of this protein the We previously reported that sequences upstream of
basal activity of the HIV LTR is very low despite of binding the HIV-1 promoter/enhancer suppress HIV LTR activity
sites for common cellular stimulators of transcription, in persistently HIV-1-infected low-producer astrocytoma
suggesting a negative regulation of basal HIV LTR activ- cell line TH4-7-5 (5, 20, 29) by comparing chlorampheni-
col acetyltransferase (CAT) reporter gene activities of an
HIV–LTR–CAT construct lacking sequences upstream
1 To whom correspondence and reprint requests should be ad-
of0158 with an undeleted construct in transient transfec-dressed at Institut fu¨r Molekulare Virologie, GSF-Forschungszentrum
tion assays (5). Like in other studies addressing negativefu¨r Umwelt and Gesundheit, GmbH, Ingolsta¨dter Landstraße 1, D-85758
Neuherberg, Germany. Fax: 89 3187 4400. E-mail: brack@gsf.de. regulation of the LTR (13, 32, 35), the undeleted construct
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contained the NRE and an additional 150-bp segment of
the nef gene upstream of the LTR (designated the nef
partial sequence (nps)) (Fig. 1, construct A). Here we
compared the effect of different viral DNA segments con-
tained in the nef gene and the LTR on suppression of
HIV LTR activity in human fibroblast (LC5) and human
astrocytoma cells (85HG66) and their persistently HIV-
infected derivatives (HIV producer fibroblast cell line
LC5-HIV (25) and low-producer astrocytoma cell line
TH4-7-5). Various sections of the HIV sequences were
deleted from construct A to generate constructs B, C, D,
and E (Fig. 1). To map potential HIV-suppressive se-
quences, reporter gene activities of the deleted con-
structs relative to the undeleted constructs were deter-
mined in parallel transfection assays (see legend to Fig.
2). We carried out a total of 338 transfection experiments
comprising 709 individual assays (electroporations) of
which 195 transfections representing 372 individual
assays are compiled into Figs. 2–4. Interassay variability
within an individual transfection experiment (two to eight
parallel electroporations carried out with one batch of
cells) was calculated to be 1.35 { 0.39-fold. This corre-
sponds to a range of relative LTR activity from 57 to 175%
(mean variability / 1 SD), which is indicated by gray
shading in Figs. 2 to 4. Mean relative LTR activities within
this range were not considered to be significant.
Figure 2 shows the results of 10 to 16 independent
FIG. 1. Structure of HIV–CAT plasmid constructs. In constructs A–D,
transfection experiments in four different cell lines com- transcription of the CAT reporter gene is directed by sequences of the LTR
paring CAT reporter gene activities of undeleted con- of HIV-1BRU in a pBR322-derived vector (pSB1). The relative location of the
HIV nef/LTR segment used for construction of plasmids A through E in thestruct A with construct B containing only HIV LTR se-
proviral genome is shown at the top. Constructs A and B were kindlyquences between positions 0158 and /83 (Fig. 1). The
provided by S. Saragosti, Hoˆpital Cochin, Paris, France, and M. Khim, Uni-activity of the HIV–LTR construct lacking sequences up-
versite´ Libre de Bruxelles, Brussels, Belgium, respectively. Nucleotide posi-
stream of 0158 (construct B) was set at 100% and the tions of HIV-1 sequences refer to the HIV-1BRU proviral genome sequence
relative activity of the undeleted construct (construct A) in GenBank85 (AC, K02013; ID, HIVBRUCG). pHIV[nps-LTR]-CAT (construct
A; positions 8491 to 9216 of HIV-1BRU) contains a segment of the HIV-1was calculated (for details, see legend to Fig. 2). In HIV-
proviral genome consisting of 189 nucleotides of the nef gene and theinfected astrocytoma cells the mean activity of the full-
adjacent 3* LTR sequences up to 83 nucleotides downstream of the tran-length LTR–promoter construct A was reduced to 25%
scription start site. Additional reporter plasmids containing specific HIV nef/
of the deleted construct in the presence of a cotrans- LTR segments were generated by digestion of construct A with appropriate
fected tat expression plasmid (Fig. 2) and to 14.5% in the restriction enzymes and religation of blunt ends of the truncated HIV reporter
plasmid fragment after treatment with Klenow enzyme. pHIV[Dnps-absence of a tat expression plasmid (data not shown).
LTRDNRE]-CAT (construct B; positions 8975 to 9216 of HIV-1BRU) lacks theThis indicates suppression of HIV LTR activity by se-
nef partial sequence and the NRE. For generation of pHIV[nps-LTRDNRE]-quences contained in the full-length construct A and ab-
CAT (construct C; positions 8491 to 8646 and 8975 to 9216 of HIV-1BRU)sent from construct B. No significant reduction of the the NRE was removed from construct A by digestion with AvaI and BglII.
mean activity of construct A was evident in the other pHIV[Dnps-LTR]-CAT (construct D; positions 8646 to 9216) was generated
by digestion of construct A with NruI (recognition site in vector) and BglII,three cell lines in either the presence (Fig. 2) or the
thus removing 321 bp of the vector sequence and 157 bp of the nef partialabsence (data not shown) of the cotransfected tat ex-
sequence. pHIV[nps-DLTR]-CAT (construct E; positions 8491–8646) con-pression plasmid.
tains no promoter elements of HIV and was generated by digestion of
The negative regulatory effect in the infected astrocy- construct A with BglII and HindIII. Positions of HIV-1-derived sequences in
toma cells could be caused by the NRE region, by the the above constructs were verified by extensive restriction enzyme mapping
and nucleotide sequence analysis by the dideoxy-mediated chain termina-extra-LTR nef sequence (nps), or by a combination of
tion method as described in ref. 29. Dotted lines indicate truncated regionsboth regions. To investigate a potential suppressive ef-
of the nef/LTR segment in plasmids B–E. U3 indicates the unique 3* region,fect of the NRE region, we carried out pairwise compari-
R the repeat region, and U5 the unique 5* region of the LTR. nps, nef partial
sons of activities of constructs differing in only the pres- sequence. NRE, negative regulatory element of the LTR. E/P, enhancer/
ence and the absence of the NRE region (e.g., constructs promoter of the LTR. TAR, trans-activation-responsive element for Tat. CAT,
chloramphenicol acetyltransferase.A/C and D/B, Fig. 1).
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for any of the four cell lines (Fig. 3a). In the HIV-infected
astrocytoma cells, the NRE even showed an overall posi-
tive effect (threefold stimulation) on LTR activity. For
the other three cell lines, the mean values under the
influence of NRE (construct D) did not vary significantly
from values of the construct lacking the NRE (construct
B, 100%). The same overall effect was observed in the
presence and absence of the tat expression plasmid
(data not shown).
These results show that the observed prominent nega-
tive regulatory effect in the infected astrocytoma cells
could not be attributed to the NRE region alone. There-
fore we examined whether the NRE region had a nega-
tive regulatory effect in the presence of the nps. For this
purpose we compared activities of constructs containing
the nps and differing in either the presence or the ab-
sence of the NRE. Figure 3b shows the activity of the
construct with NRE (construct A) relative to the construct
without the NRE (construct C) in 7 to 14 independent
transfection experiments in the four different cell lines in
the presence of the tat expression plasmid. Again, the
FIG. 2. Suppression of HIV LTR activity by sequences located up-
activity of the construct containing the NRE was not re-stream of 0158 of the HIV LTR in chronically HIV-1-infected astrocy-
duced compared to the deleted construct, indicating thattoma cells. Parallel transfections of cells with construct A and construct
B, respectively (depicted at the top), by electroporation were carried the NRE does not decrease the overall LTR activity in the
out and CAT reporter gene activities determined as previously de- presence of the nef partial sequence. In the uninfected
scribed (5). Relative LTR activity was calculated by comparing CAT astrocytoma cell line, the NRE region showed an activat-
activities resulting from parallel transfections with the plasmid con-
ing tendency in the presence of the nps.struct containing the HIV DNA fragment under study (e.g., nps and/or
The NRE region of the LTR did not show a negativeNRE) and the corresponding construct lacking this DNA fragment. The
CAT activity obtained with the deleted construct was set at 100% and regulatory effect on the HIV-LTR activity in any of the cell
the relative percentual LTR activity under the influence of the additional lines investigated in this study. This was independent of
DNA fragment calculated. This is calculated for an example as follows: the presence or absence of the nef partial sequence or
CAT activity in the presence of nps and NRE (construct A; Fig. 1) 
the addition of tat expression vector. Our data confirmed6.4% and in the absence of nps and NRE (construct B)  20.7% r
that the distinct down-regulatory effect observed in therelative LTR activity in the presence of nps is 30.9% of that in the
absence of nps. Solid diamonds represent relative LTR activities (%) infected astrocytoma cells could not be attributed to the
calculated from transfection experiments in which repeated parallel NRE region.
assays of both constructs were carried out, and open diamonds repre- Consequently we investigated the possible regulatory
sent values for single assays. Solid circles represent the mean of all
influence of the 150-bp nps on the LTR activity. Thistransfection results. The modulatory effect of the HIV sequences under
was carried out by pairwise comparison of the relativestudy was considered to be significant only if the mean relative LTR
activity exceeded the 1.75-fold range of interassay variability (indicated activities of constructs differing in the presence or the
by gray shading). In each transfection experiment 107 cells were absence of the nef partial sequence, i.e., constructs A
transfected with 20 mg construct A or B. Tat expression vector (/nps) and D (0nps) and constructs C (/nps) and B
pSV2tat72 (10) was cotransfected in a ratio of 1:10 to the CAT plasmid.
(0nps). Transfections were carried out with the four cellCell lines (for details see ref. 5) and number of independent transfection
lines in the presence and absence of the tat expressionexperiments/electroporation assays for each cell line were as follows.
Astrocytoma cells: uninfected (85HG-66), 13/23; infected (TH4-7-5), 10/ plasmid. To determine the effect of the nef partial se-
20. Fibroblasts: uninfected (LC5), 17/30; infected (LC5-HIV), 13/24. quence on HIV LTR activity, the CAT activity of the con-
struct lacking the nps was set at 100% and the relative
activity of the nps-containing construct calculated. TheTo investigate a potential regulatory effect of the NRE
results obtained in the presence of the tat expressionregion in the absence of the nef partial sequence, we
plasmid are shown in Fig. 4.compared activities of the constructs D (/NRE) and B
The results of three to five independent transfection(0NRE) in the presence and absence of the tat expres-
assays carried out with a pair of constructs containingsion plasmid in four different cell lines. Figure 3a shows
the NRE (constructs A/D) are shown in Fig. 4a. In thethe results of 6 to 12 independent transfection experi-
persistently infected astrocytoma cells, the mean activityments, in which both constructs were assessed in paral-
of the LTR construct containing the nps was reduced tolel in the presence of the tat expression plasmid.
No negative regulatory effect of the NRE was observed 20% (30% without the tat expression plasmid; data not
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FIG. 3. The NRE region does not suppress HIV LTR activity in human fibroblast and astrocytoma cell lines in the absence (a) or in the presence
of the nef partial sequence (nps) (b). Parallel transfections were carried out with HIV–CAT–reporter gene constructs differing in the presence or
absence of NRE and the LTR activities of the NRE-containing plasmids relative to the respective truncated plasmids (100%) calculated. For further
details see the legend to Fig. 2. The number of independent transfection experiments/electroporation assays for each cell line was as follows.
Astrocytoma cells: uninfected (85HG-66), 12/33 in a, 12/28 in b; infected (TH4-7-5), 9/20 in a, 7/17 in b. Fibroblasts: uninfected (LC5), 12/26 in a, 16/
30 in b; infected (LC5-HIV), 6/12 in a, 9/18 in b.
shown) of the construct lacking the nps, demonstrating comparisons of the activities of constructs B (100%) and
C (Fig. 4b). The presence of the nef partial sequencea negative regulatory effect of the nef partial sequence
on HIV LTR activity. No negative effect was observed in suppressed activity of the LTR construct to about 50% of
the deleted construct in the astrocytoma cell lines (in-the other cell lines.
The effect of the nef partial sequence on LTR activity fected and uninfected) and the uninfected fibroblasts. In
the absence of the tat expression plasmid, a mean nega-in the absence of the NRE was assessed by pairwise
FIG. 4. A 150-bp segment of the nef gene not contained in the LTR (nps) suppresses HIV LTR activity in the presence (a) and in the absence (b)
of the NRE region. Parallel transfections were carried out with HIV–CAT–reporter gene constructs differing in the presence or the absence of the
nps and the LTR activity of the nps-containing plasmid relative to the respective truncated plasmid calculated. For further details see the legend
to Fig. 2. The number of independent transfection experiments/electroporation assays for each cell line was as follows. Astrocytoma cells: uninfected
(85HG-66), 5/13 in a, 13/27 in b; infected (TH4-7-5), 4/10 in a, 7/16 in b. Fibroblasts: uninfected (LC5), 5/9 in a, 13/22 in b; infected (LC5-HIV), 3/6
in a, 9/17 in b.
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TABLE 1 the immediate–early promoter of CMV (pCMV-CAT) in
the presence of various concentrations of nps-containingDose-Dependent Suppression of Viral Promoter-Driven Reporter
plasmid (construct E). The presence of the nps sup-Gene Activity in Trans by nef Partial Sequence (nps)a
pressed activities of both the SV40 and the CMV promot-
Reporter plasmids MRb Relative CAT activity (%)c ers in a dose-dependent manner (Table 1). The sup-
pressive effect of the nps on the SV40 promoter was in
HIV LTR
the same range as that observed for the HIV LTR. In theBd 0.1:1 100
case of the CMV promoter a higher molar ratio of nps0.5:1 88
1.0:1 53 plasmid to CMV reporter construct was required to
2.0:1 25 achieve comparable levels of suppression.
De 0.1:1 82
In this study we have identified sequences within the0.4:1 95
coding region of HIV proviral genome which are capable0.9:1 41
1.7:1 17 of suppressing HIV LTR activity. Additional sequences
within the HIV genome have already been shown to mod-pSV2-CAT f 0.08:1 105
ulate HIV expression at transcriptional and posttranscrip-0.4:1 112
0.8:1 53 tional levels (6, 28, 40). An intragenic element that sup-
1.7:1 25 presses transcriptional activity of the 3* LTR in favor of
the 5* LTR has been identified in a 0.3-kb segment of thepCMV-CAT g 0.4:1 116
2.0:1 65 leader of avian retroviruses (4). Furthermore, intragenic
4.0:1 22 enhancers of LTR-dependent transcription have been
identified in the gag gene of Rous sarcoma virus (33) anda Transfections were carried out in chronically HIV-1-infected astro-
the pol/vif genes of HIV (37, 40, 42). These observationscytoma cell line TH4-7-5.
b Molar ratio of nps to promoter. suggest that the occurrence of modulators of LTR activity
c CAT activity relative to transfection in the absence of nps. within coding sequences may be a principle in regulation
d pHIV[nps-LTRDNRE]-CAT; Fig. 1. of retroviral gene expression.e pHIV[nps-LTR]-CAT; Fig. 1.
The nef gene partially overlaps the 3* LTR. Thus it hasf In pSV2CAT transcription of the CAT reporter gene is directed by
the SV40 early promoter/enhancer (14). a dual function in that it constitutes the transcriptional
g pCMVCAT was generated by ligation of an 896-bp fragment of modulatory region of the 3* LTR in addition to encoding
pRc/CMV plasmid (Invitrogen) containing the immediate–early CMV the Nef protein. Furthermore, we found that a non-LTR
promoter/enhancer with the polylinker region of pUCCAT-1 (21).
segment of nef, which we call the nps, can repress HIV
LTR activity in a cell-specific manner. Western blot analy-
sis did not provide evidence for a protein-encoding activ-tive effect of the nef partial sequence was observed only
ity of this nef partial sequence (data not shown), indicat-in the infected astrocytoma cells (data not shown).
ing that the repressive activity is a function of its nucleo-To investigate whether nps can influence HIV LTR-
tide sequences.dependent gene expression in trans, we cotransfected
The strategy previously employed to identify the NRE ofHIV–LTR constructs lacking the nps (constructs D and
the LTR was comparison of HIV LTR-dependent reporterB, respectively) with various amounts of an nps-con-
gene constructs lacking the NRE with the correspondingtaining CAT construct (construct E, Fig. 1). Parallel co-
undeleted constructs. Higher levels of reporter gene ex-transfections were carried out with the respective HIV
pression by deletion constructs were considered to indi-LTR plasmid and the empty CAT vector. The CAT activi-
cate a suppressive effect of the NRE on LTR activity.ties obtained in the absence of nps were set at 100%
Studies in four different cell lines indicated a two- toand the relative effect of the nps provided in trans was
sixfold reduced activity of the undeleted LTR reportercalculated.
gene construct (1, 13, 17, 32, 35). This negative regulatoryTable 1 shows the concentration-dependent trans ef-
effect was attributed solely to the NRE. However, the full-fect of the nps on activities of the constructs containing
length LTR constructs used in these studies frequentlythe deleted LTR (B) and the complete LTR (D), respec-
also contained upstream nef sequences which had beentively. A clear suppressive effect of the nps was seen at
removed together with the NRE in the corresponding LTRmolar ratios of nps to LTR ⁄ 1:1. These results indicated
deletion constructs. One exception is the study of Lu etthat the nef partial sequence is capable of suppressing
al. (22) where the nps was retained in the deleted LTRHIV LTR activity in both the presence and the absence
constructs and the NRE-dependent negative effect wasof the NRE when provided in trans.
not consistent in all experiments. The widespread useA trans-suppressive effect of nps on other viral promot-
of nps-containing reporter gene constructs to assay HIVers was investigated by assessing activities of constructs
containing the early viral promoter of SV40 (pSVCAT) or LTR activities in various cell lines leaves open reinterpre-
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tation of previously published data obtained with these nisms involved in restricting virus production in low-pro-
ducer organs such as the brain.and similar constructs.
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